Science


Posts filtered by tags: JCVI[x]


 

Under-30s should no longer be offered the AstraZeneca vaccine, UK regulators say, citing rare blood clots

Getty/WPA Pool People under the age of 30 should not be offered the AstraZeneca vaccine, UK officials said. It follows reports of very rare - and potentially fatal - blood clots in people who got the shot. Officials said the decision was taken as young people face more risk of the clots, and less risk from COVID-19. See more stories on Insider's business page. The AstraZeneca coronavirus vaccine should not be given to people under the age of 30, UK officials said Wednesday.The UK'...
Tags: UK, England, Science, White House, US, Trends, Eu, Daily Mail, Italy, News UK, Astrazeneca, JCVI, MHRA, Regulatory Agency MHRA, Jonathan Van Tam, Medicines and Healthcare


Vaccine confidence fears as under-30s in UK offered AstraZeneca alternative

Experts warn of impact after advice changes in response to 79 blood clot cases out of 20m vaccinationsJab fears may play into hands of anti-vaxxersCoronavirus – latest UK updatesSee all our coronavirus coverageExperts warned of damage to confidence in the UK’s vaccine programme after 10 million adults under 30 were told they will be offered an alternative to the Oxford/AstraZeneca jab following concerns over rare blood clots.Healthy 18- to 29-year-olds who are not at high risk of Covid should ha...
Tags: Health, UK, Science, Society, UK News, World news, Medical Research, Infectious Diseases, Astrazeneca, Vaccines and immunisation, JCVI, Coronavirus, Oxford AstraZeneca


Alternative to Oxford/AstraZeneca could damage vaccine confidence, say experts

Option offered to under-30s after UK records 79 cases of rare blood clots out of 20m jabs administeredJab fears may play into hands of anti-vaxxersCoronavirus – latest UK updatesSee all our coronavirus coverageExperts warned of damage to confidence in the UK’s vaccine programme after 10 million adults under 30 were told they will be offered an alternative to the Oxford/AstraZeneca jab following concerns over rare blood clots.Healthy 18- to 29-year-olds who are not at high risk of Covid should ha...
Tags: Health, UK, Science, Society, UK News, World news, Medical Research, Infectious Diseases, Vaccines and immunisation, JCVI, Coronavirus, Oxford AstraZeneca


Coronavirus live news: Johnson & Johnson jab 'to get EU approval'; Berlin pupils allowed to repeat school year

EMA expected to approve vaccine on 11 March; all pupils in German capital to have chance to repeat a year; global deaths pass 2.5mSingle Pfizer jab can reduce asymptomatic Covid infections by 75%Biden hails 50m vaccine doses since he took office What we know about the California coronavirus variantWords matter: how New Zealand’s clear messaging helped beat CovidUK coronavirus updates – live 12.09pm GMT Berlin school pupils are to be given the opportunity to repeat the current school year, in...
Tags: UK, Science, California, Germany, Berlin, Eu, World news, Infectious Diseases, New Zealand, Vaccines and immunisation, Johnson, Biden, JCVI, Coronavirus, Joint Committee on Vaccination and Immunisation


All people with learning disabilities will be invited for Covid vaccines, says care minister

Adults with less severe conditions will be invited for jabs, says Helen Whately, after advice from the Joint Committee on Vaccination and ImmunisationCoronavirus – latest updatesSee all our coronavirus coverageAll adults on the learning disability register will be invited to get a coronavirus vaccine following advice from the Joint Committtee on Vaccination and Immunisation.Those with severe learning disabilities are already included in priority group six, while adults with less severe condition...
Tags: Science, Biology, UK News, World news, Medical Research, Infectious Diseases, Microbiology, Vaccines and immunisation, Joint Committee, JCVI, Helen Whately, Coronavirus, Joint Committtee


Reports that AstraZeneca's vaccine is less effective in older people appear to be based on botched statistics, the German government says

82-year-old Brian Pinker receives the Oxford University/AstraZeneca COVID-19 vaccine. Steve Parsons - WPA Pool/Getty Images Media reports that AstraZeneca's COVID-19 vaccine is less effective in older people appear to be without merit. Reports in German media outlets Handelsblatt and Bild suggested the vaccine had an efficacy rate of 10% or less for those over 65. But the reports had "mixed up" the data, the German health ministry said. Visit Business Insider's homepage for more stories. R...
Tags: Health, UK, Science, Trends, Eu, Astrazeneca, University of Bristol, Vaccine, University of Oxford, Oxford University, Financial Times, Axel Springer, Reuters, Handelsblatt, Bild, European Medicines Agency


UK vaccine adviser says delay of Covid second dose will save lives

JCVI deputy chair defends extended gap between jabs as Hancock warns end of restrictions ‘long way off’Coronavirus – latest updatesSee all our coronavirus coverageA representative of the UK’s vaccine advisory committee has defended its decision to delay a second dose, saying it will “save many lives”, as the health secretary, Matt Hancock, warned lifting restrictions was “a long, long way off”.Prof Anthony Harnden of the Joint Committee on Vaccination and Immunisation (JCVI) said the evidence wa...
Tags: Health, Politics, UK, Science, Society, UK News, Health policy, Vaccines and immunisation, Hancock, Matt Hancock, JCVI, Coronavirus, Anthony Harnden



Filters
February - 2021
MoTuWeThFrSaSu
1234567
891011121314
15161718192021
22232425262728
March - 2021
MoTuWeThFrSaSu
1234567
891011121314
15161718192021
22232425262728
293031    
April - 2021
MoTuWeThFrSaSu
   1234
567891011
12131415161718
19202122232425
2627282930